Azurity Pharmaceuticals, Inc. recalls
Every recall we track for Azurity Pharmaceuticals, Inc. — 4 in all, from 2021–2024 — plus the complaints and injury reports the public filed about them.
Recalls per year, by danger level
4 recalls since 2017.
All FDA recall records for Azurity Pharmaceuticals, Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 1 | 0 | 1 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 1 | 1 | 2 |
| 2024 | 0 | 0 | 0 | 1 | 1 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
What to do if you have a recalled Azurity Pharmaceuticals, Inc. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Azurity Pharmaceuticals, Inc. recalls
4 shown- UnratedDrug
Azurity Pharmaceuticals, Inc. recalls Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals,
Azurity Pharmaceuticals recalls Zenzedi (Dextroamphetamine Sulfate) 30mg tablets due to potential label mix-up. This CII prescription drug, sold by Arbor Pharmaceuticals, requires immediate attention for safety.
AzurityJan 4, 2024 - UnratedDrug
Azurity Pharmaceuticals, Inc. recalls Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals,
Azurity Pharmaceuticals recalls Eprontia (topiramate) oral solution due to impurity detected in stability testing. This medication is prescription-only and may pose risks if impurities are present.
AzurityDec 8, 2023 - Lower riskDrug
Azurity Pharmaceuticals, Inc. recalls Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, packaged in: a) 10 mL multiple-dose vials (NDC 52536-625-10)
Azurity Pharmaceuticals recalls Testosterone Cypionate Injection due to crystals not redissolving after warming. This affects specific vial sizes and lots. Contact for details.
AzurityFeb 15, 2023 - Lower riskDrug
Azurity Pharmaceuticals, Inc. recalls Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing
Azurity Pharmaceuticals recalls Firvanq (vancomycin hydrochloride for oral solution) kits with incorrect diluent component. This may cause improper dosing. Consumers should contact the manufacturer for details.
AzurityAug 24, 2021
Azurity Pharmaceuticals, Inc. recall questions
How many recalls has Azurity Pharmaceuticals, Inc. had?
4 recalls from Azurity Pharmaceuticals, Inc. are on record with U.S. safety agencies, from 2021–2024.
What is the most recent Azurity Pharmaceuticals, Inc. recall?
Azurity Pharmaceuticals, Inc. recalls Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals,, dated Jan 4, 2024. Every Azurity Pharmaceuticals, Inc. recall is listed on this page, newest first.
What should I do if I have a recalled Azurity Pharmaceuticals, Inc. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Azurity Pharmaceuticals, Inc. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.